Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.
about
Fundamental issues related to the origin of melatonin and melatonin isomers during evolution: relation to their biological functionsA Review of Melatonin, Its Receptors and DrugsAging signaling pathways and circadian clock-dependent metabolic derangementsMelatonin and cortisol profiles in late midlife and their association with age-related changes in cognitionProtecting the melatonin rhythm through circadian healthy light exposureMinireview: Toward the establishment of a link between melatonin and glucose homeostasis: association of melatonin MT2 receptor variants with type 2 diabetes.Transcriptional control of antioxidant defense by the circadian clockDiscovery of 5-(4-hydroxyphenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide as a neuroprotectant for Alzheimer's disease by hybridization of curcumin and melatoninComparison of arylalkylamine N-acetyltransferase and melatonin receptor type 1B immunoreactivity between young adult and aged canine spinal cord.Out of the lab and into the bathroom: evening short-term exposure to conventional light suppresses melatonin and increases alertness perception.Melatonin, noncoding RNAs, messenger RNA stability and epigenetics--evidence, hints, gaps and perspectives.Chronobiology of Melatonin beyond the Feedback to the Suprachiasmatic Nucleus-Consequences to Melatonin Dysfunction.REM sleep deprivation promotes a dopaminergic influence in the striatal MT2 anxiolytic-like effectsMelatonin receptor genes in vertebrates.Decreased sleep quality in high myopia children.Aging, circadian rhythms and depressive disorders: a review.Comparing the Behavioural Effects of Exogenous Growth Hormone and Melatonin in Young and Old Wistar RatsMechanisms of Melatonin in Alleviating Alzheimer's Disease.Illuminating a Risk for Breast Cancer: A Preliminary Ecological Study on the Association Between Streetlight and Breast Cancer.Melatonin and Hippo Pathway: Is There Existing Cross-Talk?Sleep, Melatonin, and the Menopausal Transition: What Are the Links?The Angiotensin-melatonin axis.Association between single nucleotide polymorphisms of TPH1 and TPH2 genes, and depressive disorders.
P2860
Q22305604-EA1ACF75-AA82-4D4C-91E3-A431FABB9C00Q26739890-7FC9F574-74F3-408D-B681-16B895C0286BQ27014722-AE7A78FA-FFC9-4AED-B37C-F52585403C09Q28385283-EBA47FAA-F217-4EA9-9F24-1558D9E7404CQ28385442-9B6D7B40-903F-41FE-B789-CA3209857A04Q33669634-7621A90C-9643-456D-B18E-8AC3D965B49DQ33687785-A9367069-2410-4AF4-A62A-FFC7BFE6FC9EQ34074924-28BECAC8-1DB9-4816-9E11-04678334FC35Q34258522-66847CF3-0E50-4517-AA84-9F7544B4E8FDQ34324919-2EF5A3F7-04C2-44B9-962D-EB727AAA8DEDQ34486777-BA340A49-D857-4AF8-A773-39095039E291Q36790442-C2899AD3-1010-4C3F-8B61-7AF5B3327D21Q36903829-AADBA7D1-0D51-44FC-85DB-2210615A781CQ37007133-0BD0C97F-4648-4F64-86F6-D01228EBCB0FQ37271753-C6409611-27A8-4F0B-B2EF-EA4E061C6C12Q37366995-015160A4-7840-4F78-A0CA-EBA2A1111D4EQ37512676-C856B49E-B6A9-4E63-91D7-5B0B92D785C2Q39178920-A20B6C24-1871-4E31-99B4-21C1CF6337B7Q40424657-D8D5A72C-D98A-41FE-A85A-A7A74C3A2DB2Q41660894-B23A8AB0-2EFE-4218-AEA6-6EDF2121BFDEQ41668985-930E4751-ACFE-48CC-A504-DE3DB30C120DQ43017975-BF08061F-D131-43F8-95E0-68591FDC35CDQ47660714-B929B85E-9C8A-4EE8-98B8-31264B271143
P2860
Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Melatonin in aging and disease ...... tions and limits of treatment.
@ast
Melatonin in aging and disease ...... tions and limits of treatment.
@en
type
label
Melatonin in aging and disease ...... tions and limits of treatment.
@ast
Melatonin in aging and disease ...... tions and limits of treatment.
@en
prefLabel
Melatonin in aging and disease ...... tions and limits of treatment.
@ast
Melatonin in aging and disease ...... tions and limits of treatment.
@en
P2860
P1433
P1476
Melatonin in aging and disease ...... ptions and limits of treatment
@en
P2093
Rüdiger Hardeland
P2860
P304
P577
2011-02-10T00:00:00Z